Compression of coated drug beads for sustained release tablet of glipizide: formulation, and dissolution

References

• Bodmeier R. Tableting of coated pellets. Eur J Pharm Biopharm 1997;43:1–8
   Web of Science ®Google Scholar
• El-Gazayerly ON, Vipaporn R, Ayres JW. Novel chewable sustained-release tablet containing Verapamil hydrochloride. Pharm Dev Technol 2004;9:181–8
   PubMed Web of Science ®Google Scholar
• Vergote GJ, Kiekens F, Vervaet C, Remon JP. Wax beads as binder/disintegrant agents during the compression of coated diltiazem pellets. Eur J Pharm Sci 2002;17:145–51
   PubMed Web of Science ®Google Scholar
• Dashevsky A, Kolter K, Bodmeier R. Compression of pellets coated with various aqueous polymer dispersions. Int J Pharm 2004;279:19–26
   PubMed Web of Science ®Google Scholar
• Khan MZ, Prberg Z, Kurjakovic N. A pH-dependent colon targeted oral drug delivery system using methacrylic acid polymers. I. Manipulation of drug release using Eudragit l100-55 and Eudragit S100 combinations. J Control Release 1999;58:215–22
   PubMed Web of Science ®Google Scholar
• Chourasia MK, Jain SK. Design and development of multiparticulate system for targeted drug delivery to colon. Drug Deliv 2004;11:201–7
   PubMed Web of Science ®Google Scholar
• Khan MS, Sridhar BK, Srinatha A. Development and evaluation of pH-dependent micro beads for colon targeting. Indian J Pharm Sci 2010;72:19–23
   Google Scholar
• Song M, Li N, Tiedt LR, et al. Preparation and characterization of highly porous direct compression carrier particle with improved drug loading during an interactive mixing process. AAPS PharmSciTech 2010;11:698–707
   PubMed Web of Science ®Google Scholar
• Yoshida T, Tasaki T, Meada A, et al. Optimization of salting-out taste-masking system for micro-beads containing drugs with high solubility. Chem Pharm Bull 2008;56:1579–84
   PubMed Web of Science ®Google Scholar
• Aburaham MH, Hamza Y-S. Novel sustained-release fast-disintegrating multi-unit compressed tablets of lornoxicam containing Eudragit RS coated chitosan-alginate beads. Pharm Dev Technol 2011;16:316–30
   PubMedGoogle Scholar
• Hamman JH. Chitosan based polyelectrolyte complexes as potential carrier materials in drug delivery systems. Marine Drugs 2010;8:1305–22
   PubMed Web of Science ®Google Scholar
• Gulbake A, Jain SK. Chitosan: a potential polymer for colon-specific drug delivery system. Expert Opinion Drug Deliv 2012;9:713–29
   PubMed Web of Science ®Google Scholar
• Elzoghby AO, El-Fotoh WS, Elgindy NA. Casein-based formulations as promising controlled release drug delivery systems. J Control Release 2011;153:206–16
   PubMed Web of Science ®Google Scholar
• Bansal P, Vasireddy S, Parikh D. Effect of compression on the release properties of polymer coated niacin granules. J Control Release 1993;27:157–63
   Web of Science ®Google Scholar
• Bechard SR, Leroux JC. Coated pelletized dosage form: effect of compaction on drug release. Drug Dev Ind Pharm 1992;18:1927–44
   Web of Science ®Google Scholar
• Altaf SA, Hoag SW, Ayres JW. Bead compacts. II. Evaluation of rapidly disintegrating nonsegregating compressed bead formulations. Drug Dev Ind Pharm 1999;25:635–42
   PubMed Web of Science ®Google Scholar
• Maganti L, Çelik M. Compaction studies on pellets: II. Coated pellets. Int J Pharm 1994;20:55–67
   Google Scholar
• Altaf SA, Hoag SW, Ayres JW. Bead compacts. I. Effect of compression on maintenance of polymer coat integrity in multilayered bead formulations. Drug Dev Ind Pharm 1998;24:737–46
   PubMed Web of Science ®Google Scholar
• Mount DL, Schwartz JB. Formulation and compaction of nonfracturing deformable coated beads. Drug Dev Ind Pharm 1996;22:609–21
   Web of Science ®Google Scholar
• Cantor SL, Hoag SW, Augsberger LL. Formulation and characterization of compacted multiparticulate system for modified release of water soluble drugs-part1-acetominophen. Drug Dev Ind Pharm 2009a;35:335–51
   Google Scholar
• Cantor SL, Hoag SW, Augsberger LL. Formulation and characterization of compacted multiparticulate system for modified release of water soluble drugs-part2-acetominophen. Drug Dev Ind Pharm 2009b;35:568–82
   PubMed Web of Science ®Google Scholar
• Cantor SL, Hoag SW, Ellison CD, et al. NIR spectroscopy applications in the development of a compacted multiparticulate system for modified release. AAPS PharmSciTech 2011;12:262–78
   PubMed Web of Science ®Google Scholar
• Chuong MC, Christensen JM, Ayres JW. New dissolution method for mesalamine tablets and capsules. Dissol Technol 2008;15:7–14
   Google Scholar
• Chuong MC, Christensen JM, Ayres AW. Sustained delivery of intact drug to the colon: mesalamine formulation and temporal gastrointestinal transit analysis. Pharm Dev Technol 2009;14:116–25
   PubMedGoogle Scholar
• Bendas ER, Christensen JM, Ayres JW. Development and in-vitro evaluation of mesalamine delayed-release pellets and tableted reservoir-type pellets. Drug Dev Indus Pharmacy 2010;36:393–404
   PubMed Web of Science ®Google Scholar
• Nguyen C, Christensen JM, Ayres JW. Novel mesalamine-loaded beads in tablets for delayed release of drug to the colon. Pharm DevTechnol 2012;17:73–83
   PubMed Web of Science ®Google Scholar
• Patel JK, Patel RP, Amin AF, Patel MM. Formulation and evaluation of mucoadhesive glipizide microspheres. AAPS PharmSciTech 2005;6:E49–55
   PubMed Web of Science ®Google Scholar
• Gan Y, Pan W, Wei M, Zhang R. Cyclodextrin complex osmotic tablet for glipizide delivery. Drug Dev Ind Pharm 2002;28:1015–21
   PubMed Web of Science ®Google Scholar
• Defang O, Shufang N, Wei L. In vitro and in vivo evaluation of two extended release preparations of combination metformin and glipizide. Drug Dev Ind Pharm 2005a;31:677–85
   PubMed Web of Science ®Google Scholar
• Defang O, Shufang N, Wei L, et al. Design and evaluation of compound metformin/glipizide elementary osmotic pump tablets. J Pharm Pharmacol 2005b;57:817–20
   PubMed Web of Science ®Google Scholar
• Jamzad S, Fassihi R. Development of a controlled release low dose class II drug-glipizide. Int J Pharm 2006;32:24–32
   Google Scholar
• Hsieh S, Lin J, Chang H, et al. Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in Chinese patients: a randomized, double-blind, double-dummy, parallel-group, 12-week clinical study. Clin Therap 2006;28:1318–26
   PubMed Web of Science ®Google Scholar
• Shivakumar HN, Patel P, Desai B, et al. Design and statistical optimization of glipizide loaded lipospheres using response surface methodology. Acta Pharm 2007;57:269–85
   PubMedGoogle Scholar
• Ghosh A, Bhaumik UK, Bose A, et al. Extended release dosage form of glipizide: development and validation of a level A in vitro-in vivo correlation. Biol Pharm Bull 2008;31:1946–51
   PubMed Web of Science ®Google Scholar
• The United State Pharmacopoeia and National Formulary (USP32-NF 27). Vol. 1. Rockville, MD: United States Pharmacopoeia Convention; 2009:263--70
   Google Scholar
• Seedher N, Kanojia M. Co-solvent solubilization of some poorly-soluble antidiabetic drugs. Pharm Dev Technol 2009;14:185–92
   PubMed Web of Science ®Google Scholar
• Costa P, Lobo JMS. Modeling and comparison of dissolution profile. Eur J Pharm Sci 2001;13:123–33
   PubMed Web of Science ®Google Scholar
• Palmieri GF, Wehrle P, Martelli S. Drug release from compressed Eudragit RS 30D coated beads. Pharma Sci 1996;6:118–21
   Google Scholar
• Ueda S, Hata T, Asakura S, et al. Development of a novel drug release system, time-controlled explosion system (TES). I. Concept and design. J Drug Target 1994;2:35–44
   PubMed Web of Science ®Google Scholar
• Siepmann J, Siepmann F. Modeling of diffusion controlled drug release. J Control Release 2012;161:351–62
   PubMed Web of Science ®Google Scholar
• Nguyen CN, Christensen JM, Ayres JW. Formulation of sustained-release Verapamil HCl and Diltiazem HCl semisolid matrix capsules. Pharm Dev Technol 2008;13:115–25
   PubMed Web of Science ®Google Scholar
• Muschert S, Siepmann F, Leclercq B, et al. Prediction of drug release from ethylcellulose coated pellets. J Control Release 2009a;135:71–9
   PubMed Web of Science ®Google Scholar
• Muschert S, Siepmann F, Leclercq B, et al. Drug release mechanisms from ethylcellulose:PVA-PEG graph copolymer-coated pellets. Eur J Pharm Biopharm 2009b;72:130–7
   PubMed Web of Science ®Google Scholar
• Davis SS, Hardy JG, Taylor MJ, et al. The effect of food on the gastrointestinal transit of pellets and an osmotic device (Osmet). Int J Pharm 1984;21:331–40
   Web of Science ®Google Scholar
• Cutler D. Linear systems analysis in pharmaceutics. Pharmacokin Biopharm 1978;6:227–41
   PubMedGoogle Scholar
• Gillespie WR. Convolution-based approaches for in-vivo-in-vitro correlation modeling. Adv Exp Med Biol 1997;423:53–65
   PubMed Web of Science ®Google Scholar
• Veng-Petersen P. Noncompartmentally-based pharmacokinetic modeling. Adv Drug Deliv Rev 2001;48:265–300
   PubMedGoogle Scholar
• Watnanalumlerd P, Christensen JM, Ayres JW. Pharmacokinetic modeling and simulation of gastrointestinal transit effects on plasma concentrations of drugs from mixed immediate-release and enteric coated formulations. Pharm Dev Technol 2007;12:193–202
   PubMedGoogle Scholar